Recent controversy about access and IP Will India risk the wrath of many of its trading partners by issuing more compulsory licences to give access to innovative medicines? The question has flared to life again over the past few weeks. In early March, US trade groups sounded triumphal: India had assured the Americans that it would respect the … [Read more...] about What India will really do about access to innovative medicines
compulsory license
India may start seizing #patent rights for #greenenergy
There is a long and complicated tussle over patents in the pharma sector in India. Over the year, India has issued two compulsory licences for pharmaceuticals and made a number of other moves seen as hostile to patent holders (see this recent article on our sister site, Health Issues India) Now, according to Business Line (part of the respected … [Read more...] about India may start seizing #patent rights for #greenenergy
The Three Commitments
Why Consultants end up not telling the truth
The worst kind of market research interviewing technique ever
Why bright people can’t explain themselves
